Search

Author/Creator Schjesvold, F.

2. P889: WILL OUTCOME IMPROVE BY TREATING MULTIPLE MYELOMA PATIENTS AT MRD RELAPSE? THE REMNANT STUDY (RELAPSE FROM MRD NEGATIVITY AS INDICATION FOR TREATMENT). (23rd June 2022)

Authors:
Askeland, F. B.; Rasmussen, A.-M.; Lysen, A.; Haukås, E.; Eilertsen, A.; Moksnes, M.; Tsykunova, G.; Vik, A.; Eiken, B. D.; Sørbø, J. H.; Rolke, J.; Sand, K. O.; Hallstensen, R. F.; Myrseth, L.; Slørdahl, T. S.; Schjesvold, F.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
781
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. P901: POMALIDOMIDE, BORTEZOMIB, AND DEXAMETHASONE IN LENALIDOMIDE–PRETREATED MULTIPLE MYELOMA: A SUBANALYSIS OF OPTIMISMM BY FRAILTY. (23rd June 2022)

Authors:
Oriol, A.; Dimopoulos, M.; Schjesvold, F.; Beksac, M.; Yagci, M.; Larocca, A.; Guo, S.; Mu, Y.; Hong, K.; Dhanasiri, S.; Richardson, P.; Weisel, K.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
792
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. P937: PRECLINICAL DISCOVERY AND EARLY FINDINGS FROM THE PHASE 1, DOSE-ESCALATION STUDY OF WVT078, A BCMA-CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH R/R MULTIPLE MYELOMA. (23rd June 2022)

Authors:
Raab, M. S.; Cohen, Y. C.; Schjesvold, F.; Aardalen, K.; Oka, A.; Spencer, A.; Wermke, M.; Hari, P.; Kaufman, J. L.; Cafro, A. M.; Ocio, E. M.; Doki, N.; Henson, K.; Trabucco, G.; Juif, P.-E.; Chawla, R.; Cotton, J.; Fessehatsion, A.; Fan, L.; Blankenship, J.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
827
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. P938: CARFILZOMIB-LENALIDOMIDE-DEXAMETHASONE CONSOLIDATION IN MYELOMA PATIENTS WITH A POSITIVE FDG PET/CT AFTER UPFRONT AUTOLOGOUS STEM CELL TRANSPLANTATION: A PHASE II STUDY (CONPET). (23rd June 2022)

Authors:
Nørgaard, J. N.; Abildgaard, N.; Lysén, A.; Tsykunova, G.; Vangsted, A. J.; Joao, C.; Remen, N.; Osnes, L.; Connelly, J. P.; Revheim, M.-E. R.; Schjesvold, F.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
828
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. P950: COMBINED PROTEASOME AND AUTOPHAGY INHIBITION IN RELAPSED/REFRACTORY MULTIPLE MYELOMA – A PHASE I TRIAL OF HYDROXYCHLOROQUINE, CARFILZOMIB AND DEXAMETHASONE. (23rd June 2022)

Authors:
Slørdahl, T. S.; Askeland, F. B.; Hanssen, M. S. S.; Sundt-Hansen, S. M.; Vethe, N. T.; Hjorth-Hansen, H.; Fenstad, M. H.; Waage, A.; Hjertner, Ø.; Schjesvold, F.; Sundan, A.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
840
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search